Scilex Holding (SCLX) Amortization of Deferred Charges (2020 - 2026)

Scilex Holding (SCLX) posted quarterly Amortization of Deferred Charges of $1.0 million for Q1 2026, up 151.34% on a QoQ basis from $409000.0 in Q4 2025.

Scilex Holding (SCLX) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends

Scilex Holding (SCLX) has reported Amortization of Deferred Charges for 6 consecutive years, with $1.0 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2026 stood at $1.4 million (up 404.21% YoY), while the FY2025 annual figure was $409000.0, up 29.43% from the prior year.
  • Amortization of Deferred Charges came in at $1.0 million for Q1 2026 at Scilex Holding, up from $409000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $1.9 million in Q1 2022, with the low at $1000.0 in Q2 2023.
  • Average Amortization of Deferred Charges over 5 years is $381538.5, with a median of $34000.0 recorded in 2022.
  • Across the five-year window, Amortization of Deferred Charges tumbled 99.92% in 2023 and surged 3100.0% in 2024, its largest moves.
  • Year by year, Amortization of Deferred Charges stood at $34000.0 in 2022, then dropped by 8.82% to $31000.0 in 2023, then soared by 616.13% to $222000.0 in 2024, then surged by 84.23% to $409000.0 in 2025, then soared by 151.34% to $1.0 million in 2026.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $1.0 million, $409000.0, and $222000.0 for Q1 2026, Q4 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.03 Mn
Mar 31, 2026 1.03 Mn
Dec 31, 2025 409,000.00
Dec 31, 2025 409,000.00
Dec 31, 2024 222,000.00
Dec 31, 2024 222,000.00
Sep 30, 2024 31,000.00
Sep 30, 2024 31,000.00
Jun 30, 2024 32,000.00
Jun 30, 2024 32,000.00
Mar 31, 2024 31,000.00
Mar 31, 2024 31,000.00
Dec 31, 2023 31,000.00
Dec 31, 2023 31,000.00
Sep 30, 2023 33,000.00
Sep 30, 2023 33,000.00
Jun 30, 2023 1,000.00
Jun 30, 2023 1,000.00
Dec 31, 2022 34,000.00
Dec 31, 2022 34,000.00